Clinical Trials Browser

Phase 1/2 × belzutifan × 90 days × Clear all

NCT07049926 2026-02-19

MK-3475-03C

Phase 1/2 Recruiting

Carcinoma, Renal Cell

NCT02861573 2026-02-17

KEYNOTE-365

Phase 1/2 Recruiting

Metastatic Castration-Resistant Prostate Cancer

NCT04626479 2026-02-12

MK-3475-03A

Phase 1/2 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Renal Cell

NCT05468697 2026-01-23

MK-6482-024

Phase 1/2 Active not recruiting

Carcinoma, Renal Cell, Kidney Neoplasms